Global Beta-Nicotinamide Mononucleotide Market Growth 2024-2031

Report ID: 1768307 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Beta-Nicotinamide Mononucleotide Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Beta-Nicotinamide Mononucleotide by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Beta-Nicotinamide Mononucleotide by Country/Region, 2017, 2022 & 2028
    2.2 Beta-Nicotinamide Mononucleotide Segment by Type
        2.2.1 Above 98%
        2.2.2 Below 98%
    2.3 Beta-Nicotinamide Mononucleotide Sales by Type
        2.3.1 Global Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2022)
        2.3.2 Global Beta-Nicotinamide Mononucleotide Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Beta-Nicotinamide Mononucleotide Sale Price by Type (2017-2022)
    2.4 Beta-Nicotinamide Mononucleotide Segment by Application
        2.4.1 Health Care Products
        2.4.2 Cosmetics
        2.4.3 Others
    2.5 Beta-Nicotinamide Mononucleotide Sales by Application
        2.5.1 Global Beta-Nicotinamide Mononucleotide Sale Market Share by Application (2017-2022)
        2.5.2 Global Beta-Nicotinamide Mononucleotide Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Beta-Nicotinamide Mononucleotide Sale Price by Application (2017-2022)
3 Global Beta-Nicotinamide Mononucleotide by Company
    3.1 Global Beta-Nicotinamide Mononucleotide Breakdown Data by Company
        3.1.1 Global Beta-Nicotinamide Mononucleotide Annual Sales by Company (2020-2022)
        3.1.2 Global Beta-Nicotinamide Mononucleotide Sales Market Share by Company (2020-2022)
    3.2 Global Beta-Nicotinamide Mononucleotide Annual Revenue by Company (2020-2022)
        3.2.1 Global Beta-Nicotinamide Mononucleotide Revenue by Company (2020-2022)
        3.2.2 Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Company (2020-2022)
    3.3 Global Beta-Nicotinamide Mononucleotide Sale Price by Company
    3.4 Key Manufacturers Beta-Nicotinamide Mononucleotide Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Beta-Nicotinamide Mononucleotide Product Location Distribution
        3.4.2 Players Beta-Nicotinamide Mononucleotide Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Beta-Nicotinamide Mononucleotide by Geographic Region
    4.1 World Historic Beta-Nicotinamide Mononucleotide Market Size by Geographic Region (2017-2022)
        4.1.1 Global Beta-Nicotinamide Mononucleotide Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Beta-Nicotinamide Mononucleotide Annual Revenue by Geographic Region
    4.2 World Historic Beta-Nicotinamide Mononucleotide Market Size by Country/Region (2017-2022)
        4.2.1 Global Beta-Nicotinamide Mononucleotide Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Beta-Nicotinamide Mononucleotide Annual Revenue by Country/Region
    4.3 Americas Beta-Nicotinamide Mononucleotide Sales Growth
    4.4 APAC Beta-Nicotinamide Mononucleotide Sales Growth
    4.5 Europe Beta-Nicotinamide Mononucleotide Sales Growth
    4.6 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Growth
5 Americas
    5.1 Americas Beta-Nicotinamide Mononucleotide Sales by Country
        5.1.1 Americas Beta-Nicotinamide Mononucleotide Sales by Country (2017-2022)
        5.1.2 Americas Beta-Nicotinamide Mononucleotide Revenue by Country (2017-2022)
    5.2 Americas Beta-Nicotinamide Mononucleotide Sales by Type
    5.3 Americas Beta-Nicotinamide Mononucleotide Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Beta-Nicotinamide Mononucleotide Sales by Region
        6.1.1 APAC Beta-Nicotinamide Mononucleotide Sales by Region (2017-2022)
        6.1.2 APAC Beta-Nicotinamide Mononucleotide Revenue by Region (2017-2022)
    6.2 APAC Beta-Nicotinamide Mononucleotide Sales by Type
    6.3 APAC Beta-Nicotinamide Mononucleotide Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Beta-Nicotinamide Mononucleotide by Country
        7.1.1 Europe Beta-Nicotinamide Mononucleotide Sales by Country (2017-2022)
        7.1.2 Europe Beta-Nicotinamide Mononucleotide Revenue by Country (2017-2022)
    7.2 Europe Beta-Nicotinamide Mononucleotide Sales by Type
    7.3 Europe Beta-Nicotinamide Mononucleotide Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Beta-Nicotinamide Mononucleotide by Country
        8.1.1 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue by Country (2017-2022)
    8.2 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Type
    8.3 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide
    10.3 Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide
    10.4 Industry Chain Structure of Beta-Nicotinamide Mononucleotide
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Beta-Nicotinamide Mononucleotide Distributors
    11.3 Beta-Nicotinamide Mononucleotide Customer
12 World Forecast Review for Beta-Nicotinamide Mononucleotide by Geographic Region
    12.1 Global Beta-Nicotinamide Mononucleotide Market Size Forecast by Region
        12.1.1 Global Beta-Nicotinamide Mononucleotide Forecast by Region (2023-2028)
        12.1.2 Global Beta-Nicotinamide Mononucleotide Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Beta-Nicotinamide Mononucleotide Forecast by Type
    12.7 Global Beta-Nicotinamide Mononucleotide Forecast by Application
13 Key Players Analysis
    13.1 GeneHarbor
        13.1.1 GeneHarbor Company Information
        13.1.2 GeneHarbor Beta-Nicotinamide Mononucleotide Product Offered
        13.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 GeneHarbor Main Business Overview
        13.1.5 GeneHarbor Latest Developments
    13.2 Herbalmax
        13.2.1 Herbalmax Company Information
        13.2.2 Herbalmax Beta-Nicotinamide Mononucleotide Product Offered
        13.2.3 Herbalmax Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Herbalmax Main Business Overview
        13.2.5 Herbalmax Latest Developments
    13.3 Genex Formulas
        13.3.1 Genex Formulas Company Information
        13.3.2 Genex Formulas Beta-Nicotinamide Mononucleotide Product Offered
        13.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Genex Formulas Main Business Overview
        13.3.5 Genex Formulas Latest Developments
    13.4 Shinkowa Pharmaceutical
        13.4.1 Shinkowa Pharmaceutical Company Information
        13.4.2 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Product Offered
        13.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Shinkowa Pharmaceutical Main Business Overview
        13.4.5 Shinkowa Pharmaceutical Latest Developments
    13.5 Maac10 Formulas
        13.5.1 Maac10 Formulas Company Information
        13.5.2 Maac10 Formulas Beta-Nicotinamide Mononucleotide Product Offered
        13.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Maac10 Formulas Main Business Overview
        13.5.5 Maac10 Formulas Latest Developments
    13.6 EffePharm
        13.6.1 EffePharm Company Information
        13.6.2 EffePharm Beta-Nicotinamide Mononucleotide Product Offered
        13.6.3 EffePharm Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 EffePharm Main Business Overview
        13.6.5 EffePharm Latest Developments
    13.7 Bontac
        13.7.1 Bontac Company Information
        13.7.2 Bontac Beta-Nicotinamide Mononucleotide Product Offered
        13.7.3 Bontac Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Bontac Main Business Overview
        13.7.5 Bontac Latest Developments
    13.8 CELFULL
        13.8.1 CELFULL Company Information
        13.8.2 CELFULL Beta-Nicotinamide Mononucleotide Product Offered
        13.8.3 CELFULL Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 CELFULL Main Business Overview
        13.8.5 CELFULL Latest Developments
    13.9 Kingdomway
        13.9.1 Kingdomway Company Information
        13.9.2 Kingdomway Beta-Nicotinamide Mononucleotide Product Offered
        13.9.3 Kingdomway Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Kingdomway Main Business Overview
        13.9.5 Kingdomway Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Beta-Nicotinamide Mononucleotide Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Beta-Nicotinamide Mononucleotide Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Above 98%
    Table 4. Major Players of Below 98%
    Table 5. Global Beta-Nicotinamide Mononucleotide Sales by Type (2017-2022) & (Tons)
    Table 6. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2022)
    Table 7. Global Beta-Nicotinamide Mononucleotide Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Type (2017-2022)
    Table 9. Global Beta-Nicotinamide Mononucleotide Sale Price by Type (2017-2022) & (US$/Ton)
    Table 10. Global Beta-Nicotinamide Mononucleotide Sales by Application (2017-2022) & (Tons)
    Table 11. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2022)
    Table 12. Global Beta-Nicotinamide Mononucleotide Revenue by Application (2017-2022)
    Table 13. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Application (2017-2022)
    Table 14. Global Beta-Nicotinamide Mononucleotide Sale Price by Application (2017-2022) & (US$/Ton)
    Table 15. Global Beta-Nicotinamide Mononucleotide Sales by Company (2020-2022) & (Tons)
    Table 16. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Company (2020-2022)
    Table 17. Global Beta-Nicotinamide Mononucleotide Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Company (2020-2022)
    Table 19. Global Beta-Nicotinamide Mononucleotide Sale Price by Company (2020-2022) & (US$/Ton)
    Table 20. Key Manufacturers Beta-Nicotinamide Mononucleotide Producing Area Distribution and Sales Area
    Table 21. Players Beta-Nicotinamide Mononucleotide Products Offered
    Table 22. Beta-Nicotinamide Mononucleotide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Beta-Nicotinamide Mononucleotide Sales by Geographic Region (2017-2022) & (Tons)
    Table 26. Global Beta-Nicotinamide Mononucleotide Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Beta-Nicotinamide Mononucleotide Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Beta-Nicotinamide Mononucleotide Sales by Country/Region (2017-2022) & (Tons)
    Table 30. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Beta-Nicotinamide Mononucleotide Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Beta-Nicotinamide Mononucleotide Sales by Country (2017-2022) & (Tons)
    Table 34. Americas Beta-Nicotinamide Mononucleotide Sales Market Share by Country (2017-2022)
    Table 35. Americas Beta-Nicotinamide Mononucleotide Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Beta-Nicotinamide Mononucleotide Revenue Market Share by Country (2017-2022)
    Table 37. Americas Beta-Nicotinamide Mononucleotide Sales by Type (2017-2022) & (Tons)
    Table 38. Americas Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2022)
    Table 39. Americas Beta-Nicotinamide Mononucleotide Sales by Application (2017-2022) & (Tons)
    Table 40. Americas Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2022)
    Table 41. APAC Beta-Nicotinamide Mononucleotide Sales by Region (2017-2022) & (Tons)
    Table 42. APAC Beta-Nicotinamide Mononucleotide Sales Market Share by Region (2017-2022)
    Table 43. APAC Beta-Nicotinamide Mononucleotide Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Beta-Nicotinamide Mononucleotide Revenue Market Share by Region (2017-2022)
    Table 45. APAC Beta-Nicotinamide Mononucleotide Sales by Type (2017-2022) & (Tons)
    Table 46. APAC Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2022)
    Table 47. APAC Beta-Nicotinamide Mononucleotide Sales by Application (2017-2022) & (Tons)
    Table 48. APAC Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2022)
    Table 49. Europe Beta-Nicotinamide Mononucleotide Sales by Country (2017-2022) & (Tons)
    Table 50. Europe Beta-Nicotinamide Mononucleotide Sales Market Share by Country (2017-2022)
    Table 51. Europe Beta-Nicotinamide Mononucleotide Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Beta-Nicotinamide Mononucleotide Revenue Market Share by Country (2017-2022)
    Table 53. Europe Beta-Nicotinamide Mononucleotide Sales by Type (2017-2022) & (Tons)
    Table 54. Europe Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2022)
    Table 55. Europe Beta-Nicotinamide Mononucleotide Sales by Application (2017-2022) & (Tons)
    Table 56. Europe Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Country (2017-2022) & (Tons)
    Table 58. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Type (2017-2022) & (Tons)
    Table 62. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Application (2017-2022) & (Tons)
    Table 64. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Beta-Nicotinamide Mononucleotide
    Table 66. Key Market Challenges & Risks of Beta-Nicotinamide Mononucleotide
    Table 67. Key Industry Trends of Beta-Nicotinamide Mononucleotide
    Table 68. Beta-Nicotinamide Mononucleotide Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Beta-Nicotinamide Mononucleotide Distributors List
    Table 71. Beta-Nicotinamide Mononucleotide Customer List
    Table 72. Global Beta-Nicotinamide Mononucleotide Sales Forecast by Region (2023-2028) & (Tons)
    Table 73. Global Beta-Nicotinamide Mononucleotide Sales Market Forecast by Region
    Table 74. Global Beta-Nicotinamide Mononucleotide Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Beta-Nicotinamide Mononucleotide Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Beta-Nicotinamide Mononucleotide Sales Forecast by Country (2023-2028) & (Tons)
    Table 77. Americas Beta-Nicotinamide Mononucleotide Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Beta-Nicotinamide Mononucleotide Sales Forecast by Region (2023-2028) & (Tons)
    Table 79. APAC Beta-Nicotinamide Mononucleotide Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Beta-Nicotinamide Mononucleotide Sales Forecast by Country (2023-2028) & (Tons)
    Table 81. Europe Beta-Nicotinamide Mononucleotide Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Forecast by Country (2023-2028) & (Tons)
    Table 83. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Beta-Nicotinamide Mononucleotide Sales Forecast by Type (2023-2028) & (Tons)
    Table 85. Global Beta-Nicotinamide Mononucleotide Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Beta-Nicotinamide Mononucleotide Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Beta-Nicotinamide Mononucleotide Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Beta-Nicotinamide Mononucleotide Sales Forecast by Application (2023-2028) & (Tons)
    Table 89. Global Beta-Nicotinamide Mononucleotide Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Beta-Nicotinamide Mononucleotide Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Beta-Nicotinamide Mononucleotide Revenue Market Share Forecast by Application (2023-2028)
    Table 92. GeneHarbor Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
    Table 93. GeneHarbor Beta-Nicotinamide Mononucleotide Product Offered
    Table 94. GeneHarbor Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
    Table 95. GeneHarbor Main Business
    Table 96. GeneHarbor Latest Developments
    Table 97. Herbalmax Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
    Table 98. Herbalmax Beta-Nicotinamide Mononucleotide Product Offered
    Table 99. Herbalmax Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
    Table 100. Herbalmax Main Business
    Table 101. Herbalmax Latest Developments
    Table 102. Genex Formulas Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
    Table 103. Genex Formulas Beta-Nicotinamide Mononucleotide Product Offered
    Table 104. Genex Formulas Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
    Table 105. Genex Formulas Main Business
    Table 106. Genex Formulas Latest Developments
    Table 107. Shinkowa Pharmaceutical Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
    Table 108. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Product Offered
    Table 109. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
    Table 110. Shinkowa Pharmaceutical Main Business
    Table 111. Shinkowa Pharmaceutical Latest Developments
    Table 112. Maac10 Formulas Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
    Table 113. Maac10 Formulas Beta-Nicotinamide Mononucleotide Product Offered
    Table 114. Maac10 Formulas Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
    Table 115. Maac10 Formulas Main Business
    Table 116. Maac10 Formulas Latest Developments
    Table 117. EffePharm Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
    Table 118. EffePharm Beta-Nicotinamide Mononucleotide Product Offered
    Table 119. EffePharm Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
    Table 120. EffePharm Main Business
    Table 121. EffePharm Latest Developments
    Table 122. Bontac Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
    Table 123. Bontac Beta-Nicotinamide Mononucleotide Product Offered
    Table 124. Bontac Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
    Table 125. Bontac Main Business
    Table 126. Bontac Latest Developments
    Table 127. CELFULL Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
    Table 128. CELFULL Beta-Nicotinamide Mononucleotide Product Offered
    Table 129. CELFULL Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
    Table 130. CELFULL Main Business
    Table 131. CELFULL Latest Developments
    Table 132. Kingdomway Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
    Table 133. Kingdomway Beta-Nicotinamide Mononucleotide Product Offered
    Table 134. Kingdomway Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
    Table 135. Kingdomway Main Business
    Table 136. Kingdomway Latest Developments
List of Figures
    Figure 1. Picture of Beta-Nicotinamide Mononucleotide
    Figure 2. Beta-Nicotinamide Mononucleotide Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Beta-Nicotinamide Mononucleotide Sales Growth Rate 2017-2028 (Tons)
    Figure 7. Global Beta-Nicotinamide Mononucleotide Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Beta-Nicotinamide Mononucleotide Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Above 98%
    Figure 10. Product Picture of Below 98%
    Figure 11. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Type in 2021
    Figure 12. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Type (2017-2022)
    Figure 13. Beta-Nicotinamide Mononucleotide Consumed in Health Care Products
    Figure 14. Global Beta-Nicotinamide Mononucleotide Market: Health Care Products (2017-2022) & (Tons)
    Figure 15. Beta-Nicotinamide Mononucleotide Consumed in Cosmetics
    Figure 16. Global Beta-Nicotinamide Mononucleotide Market: Cosmetics (2017-2022) & (Tons)
    Figure 17. Beta-Nicotinamide Mononucleotide Consumed in Others
    Figure 18. Global Beta-Nicotinamide Mononucleotide Market: Others (2017-2022) & (Tons)
    Figure 19. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2022)
    Figure 20. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Application in 2021
    Figure 21. Beta-Nicotinamide Mononucleotide Revenue Market by Company in 2021 ($ Million)
    Figure 22. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Company in 2021
    Figure 23. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Geographic Region (2017-2022)
    Figure 24. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Geographic Region in 2021
    Figure 25. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Region (2017-2022)
    Figure 26. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Country/Region in 2021
    Figure 27. Americas Beta-Nicotinamide Mononucleotide Sales 2017-2022 (Tons)
    Figure 28. Americas Beta-Nicotinamide Mononucleotide Revenue 2017-2022 ($ Millions)
    Figure 29. APAC Beta-Nicotinamide Mononucleotide Sales 2017-2022 (Tons)
    Figure 30. APAC Beta-Nicotinamide Mononucleotide Revenue 2017-2022 ($ Millions)
    Figure 31. Europe Beta-Nicotinamide Mononucleotide Sales 2017-2022 (Tons)
    Figure 32. Europe Beta-Nicotinamide Mononucleotide Revenue 2017-2022 ($ Millions)
    Figure 33. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales 2017-2022 (Tons)
    Figure 34. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue 2017-2022 ($ Millions)
    Figure 35. Americas Beta-Nicotinamide Mononucleotide Sales Market Share by Country in 2021
    Figure 36. Americas Beta-Nicotinamide Mononucleotide Revenue Market Share by Country in 2021
    Figure 37. United States Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Canada Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Mexico Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Brazil Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 41. APAC Beta-Nicotinamide Mononucleotide Sales Market Share by Region in 2021
    Figure 42. APAC Beta-Nicotinamide Mononucleotide Revenue Market Share by Regions in 2021
    Figure 43. China Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Japan Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 45. South Korea Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Southeast Asia Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 47. India Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Australia Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Europe Beta-Nicotinamide Mononucleotide Sales Market Share by Country in 2021
    Figure 50. Europe Beta-Nicotinamide Mononucleotide Revenue Market Share by Country in 2021
    Figure 51. Germany Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 52. France Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 53. UK Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Italy Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Russia Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Market Share by Country in 2021
    Figure 57. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue Market Share by Country in 2021
    Figure 58. Egypt Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Africa Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Israel Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Turkey Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country Beta-Nicotinamide Mononucleotide Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide in 2021
    Figure 64. Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide
    Figure 65. Industry Chain Structure of Beta-Nicotinamide Mononucleotide
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Beta-Nicotinamide Mononucleotide Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Beta-Nicotinamide Mononucleotide Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Beta-Nicotinamide Mononucleotide Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports